Financial insights of ZNTL

MyFinsight

For the quarter ending 2025-09-30.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-12-31
License revenue	0	0	-	22,475,000
Research and development	22,950,000	27,610,000	27,247,000	39,794,000
Goodwill impairment	-	-	-	934,000
General and administrative	10,784,000	8,448,000	10,580,000	23,451,000
Restructuring	0	0	7,796,000	-
Total operating expenses	33,734,000	36,058,000	45,623,000	64,490,333.333
Loss from operations	-33,734,000	-36,058,000	-45,623,000	-42,015,333.333
Investment and other income, net	7,043,000	9,184,000	-2,656,000	16,122,333.333
Net loss before income taxes	-26,691,000	-26,874,000	-48,279,000	-25,893,000
Income tax expense (benefit)	0	0	-	-29,666.667
Net loss	-26,691,000	-26,874,000	-48,279,000	-25,863,333.333
Net loss attributable to noncontrolling interests	0	0	-	-7,000
Net loss attributable to zentalis	-26,691,000	-26,874,000	-48,279,000	-25,854,000

Net loss per common share outstanding, basic (in dollars per share)	-0.37	-0.37	-0.67	-0.363
Net loss per common share outstanding, diluted (in dollars per share)	-0.37	-0.37	-0.67	-0.363
Weighted average number of common shares outstanding, basic (in shares)	72,139,000	71,992,000	71,678,000	13,333.333
Weighted average number of common shares outstanding, diluted (in shares)	72,139,000	71,992,000	71,678,000	13,333.333